NCT05696457 is a NA clinical trial of Passive music therapy in Acute Myeloblastic Leukemia, sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz.

Who is sponsoring NCT05696457?

NCT05696457 is sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz.

What drugs are being tested in NCT05696457?

Interventions in NCT05696457: Passive music therapy.

What condition does NCT05696457 study?

NCT05696457 studies Acute Myeloblastic Leukemia, Hematopoietic Stem Cell Transplantation.

Is NCT05696457 still recruiting?

NCT05696457 is currently completed. Last updated 25 January 2023.

Last reviewed 2023-01-25 · How we verify

NCT05696457

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Music Therapy in Controlling Symptoms in Patients With AML and Undergoing HSCT

Completed NA Last updated 25 January 2023

What this trial tests

NA trial testing Passive music therapy in Acute Myeloblastic Leukemia in 71 participants. Completed in 21 November 2022.

Timeline

1 February 2021

Primary endpoint
21 November 2022

21 November 2022

Quick facts

Lead sponsor	Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	71
Start date	1 February 2021
Primary completion	21 November 2022
Estimated completion	21 November 2022
Sites	1 location across Spain

Drugs / interventions tested

Passive music therapy

Conditions studied

Acute Myeloblastic Leukemia — all drugs for Acute Myeloblastic Leukemia →
Hematopoietic Stem Cell Transplantation — all drugs for Hematopoietic Stem Cell Transplantation →

Sponsor

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz — full company profile →

Who can join

18 and older, any sex, with Acute Myeloblastic Leukemia or Hematopoietic Stem Cell Transplantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test passive music therapy in patients receiving induction chemotherapy for an acute myeloblastic leukemia or undergoing an hematopoietic stem cell transplantation. The main questions it aims to answer are: \- Can music therapy control physical and psychological symptoms and improve the mood and quality of life of these patients? Participants will be randomly assigned to the control and experimental group. Patients included in both groups will complete weekly mood and quality of life questionnaires. Those included in the experimental group will also complete daily symptom burden questionnaires before and after listening to a music therapy session. Researchers will confirm if the experimental group improves their symptoms after the music therapy session and will compare both groups to see if there are differences in mood and quality of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Music Listening in Stem Cell Transplantation and Acute Myeloid Leukemia: A Randomized Clinical Trial.
Lázaro-García A, Láinez-González D, González-Rodríguez M, Cano Alsua S, et al · · 2024 · cited 1× · PMID 38447622 · DOI 10.1016/j.jpainsymman.2024.02.567

Verify or expand the search:

Other trials of Passive music therapy

Trials testing the same drug.

NCT04761497 — Effects of Group Music Therapy Interventions on Alzheimer's Disease Patients: a Three-arm Randomized Controlled Blind St · NA · completed

Other recruiting trials for Acute Myeloblastic Leukemia

Currently open trials in the same condition.

NCT07250217 — Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients · NA · recruiting
NCT07016165 — Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Maligna · Phase 4 · recruiting

Other Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz trials

Trials by the same sponsor.

NCT07416760 — Analysis of the Composition of the Intestinal Microbiota in Patients Post-intestinal Anastomosis · recruiting
NCT07115680 — Where Did the Authors Work When They Conducted Their Clinical Pharmacology Studies? · completed
NCT07003308 — Anterior Versus Posterior White Line Advancement Technique in the Correction of Aponeurotic Ptosis · NA · recruiting
NCT06968000 — Double-blind Pilot Study on the Effect of Anionic Exposome Enrichment (Biow) on Recovery and Sleep Quality in Postoperat · Phase 1, PHASE2 · recruiting
NCT06163807 — Follow-up of Spanish Prospective Asthma and Nasal Polyposis Registry · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05696457 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Last refreshed: 25 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05696457.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing